Brief: Lyra Therapeutics Reports Fourth Quarter Results

Lyra Therapeutics

29/03/2023 22:02

March 29 (Reuters) - Lyra Therapeutics Inc  LYRA.O :
    * LYRA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * NET LOSS FOR Q4 2022 WAS $14.2 MILLION VERSUS $13.6
MILLION
    * LYRA THERAPEUTICS -EXPECTS CASH, CASH EQUIVALENTS,
SHORT-TERM
INVESTMENTS BALANCE TO BE SUFFICIENT TO FUND PLANNED OPERATIONS
INTO MID-2024
    * Q4 EARNINGS PER SHARE VIEW $-0.41 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9q48HC 
Further company coverage:  LYRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))